|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.156
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.121
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.108
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.096
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.094
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.090
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.089
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.086
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.086
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.084
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.071
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.070
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.067
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.065
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.065
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.063
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.063
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.062
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.062
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.061
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.060
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.059
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.055
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.053
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.052
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.052
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.052
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.051
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.050
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.049
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.046
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.046
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.046
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.045
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.045
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.045
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.044
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.043
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.043
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.042
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.042
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.041
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.041
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.041
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.041
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.041
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.041
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.040
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.039
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.039
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.039
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.039
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.038
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.038
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.038
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.038
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.037
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.037
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.037
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.036
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.036
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.036
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.036
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.036
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.036
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.035
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.035
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.035
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.035
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.035
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.035
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.035
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.035
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.035
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.035
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.034
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.034
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.034
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.034
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.034
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.034
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.034
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.033
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.033
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.033
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.033
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.033
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.033
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.033
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.033
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.032
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.032
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.032
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.032
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.032
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.032
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.032
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.031
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.031
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.031
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.031
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.031
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
pattern specification involved in metanephros development
|
GO:0072268 |
4 |
0.031
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.030
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.030
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.030
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.030
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.030
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.030
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.030
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.030
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.030
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.029
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.029
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.029
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.029
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.029
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.028
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.028
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.028
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.028
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.028
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.028
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.028
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.028
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.028
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.028
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.028
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.028
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.028
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.028
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.028
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.027
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.027
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.027
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.027
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.027
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.026
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.026
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.026
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.026
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.026
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.026
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.026
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.026
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.025
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.025
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.025
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.025
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.025
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.025
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.025
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.025
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.025
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.024
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.024
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.024
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.024
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.024
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.023
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.023
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.023
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.023
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.023
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.023
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.023
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.023
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.023
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.023
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.023
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.022
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.022
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.022
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.022
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.022
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.022
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.022
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.022
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.022
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.022
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.022
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.021
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.021
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.021
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.021
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.021
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.021
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.021
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.021
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.021
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.021
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.021
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.021
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.021
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.021
|
|
|
|
regulation of organ formation
|
GO:0003156 |
34 |
0.021
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.021
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.021
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.020
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.020
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.020
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.020
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.020
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.020
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.019
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.019
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.019
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.019
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.019
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.019
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.019
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.019
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.019
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.019
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.019
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.019
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.019
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.018
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.018
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.018
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.018
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.018
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.018
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.018
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.018
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.018
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.018
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.018
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.018
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.018
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.018
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.018
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.018
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.018
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.017
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.017
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.017
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.017
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.017
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.017
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.017
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.017
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.017
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.017
|
|
|
|
retinal cone cell differentiation
|
GO:0042670 |
8 |
0.017
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.017
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.017
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.017
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.017
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.017
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.017
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.017
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.017
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.017
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.017
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.017
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.017
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.017
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.017
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.016
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.016
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.016
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.016
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.016
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.016
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.016
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.016
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.016
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.016
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.016
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.016
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.016
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.016
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.016
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.016
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.016
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.016
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.016
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.016
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.016
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.016
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.016
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.016
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.016
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.016
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.016
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.016
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.016
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.016
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.016
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.016
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.016
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.015
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.015
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.015
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.015
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.015
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.015
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.015
|
|
|
|
transcription from rna polymerase iii promoter
|
GO:0006383 |
3 |
0.015
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.015
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.015
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.015
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.015
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.015
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.015
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.015
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.015
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.015
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.015
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.015
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.015
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.015
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.015
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.015
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.015
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.015
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.015
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.015
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.015
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.015
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.015
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.015
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
axial mesoderm formation
|
GO:0048320 |
3 |
0.015
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.015
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.015
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.015
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.015
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.015
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.015
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.015
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.015
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.015
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.015
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.015
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.014
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.014
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.014
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.014
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.014
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.014
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.014
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.014
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.014
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.014
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.014
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.014
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.014
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.014
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.014
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.014
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.014
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.014
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.014
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.014
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.014
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.014
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.014
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.014
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.014
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.014
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.014
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
|
negative regulation of stem cell maintenance
|
GO:1902455 |
4 |
0.014
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.014
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.014
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.014
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.013
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.013
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.013
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.013
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.013
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.013
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.013
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.013
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.013
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.013
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.013
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.013
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.013
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.013
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.013
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.013
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.013
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.013
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.013
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.013
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.013
|
|
|
|
pyramidal neuron migration
|
GO:0021852 |
1 |
0.013
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.013
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.013
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.013
|
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.013
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.013
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.013
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.013
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.013
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.013
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.013
|
|
|
|
mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:1901145 |
4 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.013
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.013
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.013
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
50 |
0.013
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.013
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.013
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.013
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.013
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.013
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.013
|
|
